Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIO-AffectDX Clinical Study

NCT04870281 is registered in ClinicalTrials.gov with Biotronik, Inc. as lead sponsor.

NCT NCT04870281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04870281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIO-AffectDX Clinical Study
Lead sponsor
Biotronik, Inc.
Phase
Observational
Overall status
Terminated
Start date
May 28, 2021
Completion date
December 29, 2021
Enrollment
13 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiac resynchronization therapy, heart failure